SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Neuromuscular Neurology Referral — Wilma Mankiller

PatientWilma Mankiller
Date of birth1991-11-18
IdentifiersMRN HR-ML052-SYN; SSN (made up) 000-52-4183
Document date2026-03-09
AuthorRena Hawkfeather-Lindqvist, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Woman of 34 with six weeks of fluctuating ptosis, diplopia and fatigable weakness of the arms, neck, chewing and voice, while recovering from a severe car crash last year: suspected generalized myasthenia gravis. Please confirm the diagnosis and advise on treatment, thymectomy and safety. [S]

Urgency: Urgent, within two weeks. [S]

Questions for the consultant:

History of Present Illness

Cherokee Nation citizen living in rural Adair County, about an hour's drive from this clinic; works for the Cherokee Nation. Head-on car crash last year with fractures of both legs, ribs and face and many operations; walks independently, with a cane on rough ground. Hereditary polycystic kidney disease, as she has described it, with normal kidney function. Examination: left-predominant ptosis after 30 seconds of upgaze, improved by 3 mm after a two-minute ice pack; diplopia on sustained lateral gaze; neck flexion 4 of 5; deltoids fatigue after 30 seconds; nasal voice after counting to 30; reflexes and sensation normal. FVC 3.30 L, negative inspiratory force -70 cm H2O, single-breath count 32. Blood count, chemistry and TSH normal; creatinine 0.78 mg/dL, eGFR 102, urine albumin 14 mg/g; hemoglobin A1c 5.3 percent. PHQ-9 score 7. Acetylcholine receptor antibodies sent; chest CT with contrast and kidney ultrasound booked. Pyridostigmine 30 mg three times daily started as a trial. No other regular medicines except acetaminophen. She would like blood tests near home where possible and her own Cherokee medicine respected [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

8 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Pyridostigmine bromide 30 mg oral tablet, one tablet three times daily with meals as a trial; take 30 to 45 minutes before eatingOne tablet three times dailyOral route2026-03-09 to 2026-03-23completedS
Acetaminophen 500 mg oral tablet, one or two tablets up to three times daily as needed for leg painOne or two tablets up to three times daily as neededOral route2025-09-15activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Drooping eyelids and double vision for six weeks, worse in the evening, with fatigable weakness of the arms and neck, tiring when chewing and a nasal voice after long talks; a disorder of the neuromuscular junction suspectedactiveconfirmed H53.2S — Synthetic presenting problem, resolved at the second visit when antibodies and nerve testing established myasthenia gravis.
Autosomal dominant polycystic kidney disease (hereditary, as she has described it), with normal kidney function; to be stagedactiveconfirmed Q61.2S — The hereditary polycystic kidney disease is documented (D) from her later public account; its detection before the index date, and every value, are synthetic.
Recovery from major trauma in a head-on car crash last year: fractures of both legs, ribs and face, with many operations; walks independently, with a cane on rough groundactiveconfirmed Z87.81S — The crash, the operations and the injuries are documented (D); the current function is synthetic.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1979 (1978 in one account)Near-fatal head-on car crash with about 17 operations, with fractures of the legs, ribs and faceD (CLM-0005)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-03-09Body height163cmS
2026-03-09Body weight61.8kgS
2026-03-09Body mass index (BMI) [Ratio]23.3kg/m2S
2026-03-09Systolic blood pressure126mm[Hg]S
2026-03-09Diastolic blood pressure82mm[Hg]S
2026-03-09Heart rate78/minS
2026-03-09Respiratory rate16/minS
2026-03-09Body temperature36.7CelS
2026-03-09Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-09Hemoglobin [Mass/volume] in Blood12.8g/dL11.6-15 g/dLNormalS
2026-03-09Leukocytes [#/volume] in Blood by Automated count6.910*3/uL4-11 10*3/uLNormalS
2026-03-09Platelets [#/volume] in Blood by Automated count26210*3/uL150-400 10*3/uLNormalS
2026-03-09Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-03-09Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-03-09Glucose [Mass/volume] in Serum or Plasma88mg/dL70-99 mg/dLNormalS
2026-03-09Creatinine [Mass/volume] in Serum or Plasma0.78mg/dL0.59-1.04 mg/dLNormalS
2026-03-09Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M102mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-09Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
2026-03-09Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma18U/L7-45 U/LNormalS
2026-03-09Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L8-43 U/LNormalS
2026-03-09Albumin [Mass/volume] in Serum or Plasma4.2g/dL3.5-5 g/dLNormalS
2026-03-09Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.45-4.5 mIU/LNormalS
2026-03-09Hemoglobin A1c/Hemoglobin.total in Blood5.3%<=5.6%NormalS
2026-03-09Albumin/Creatinine [Mass Ratio] in Urine14mg/gBelow 30 mg/g is normal (A1)NormalS
2026-03-0925-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma31ng/mL30-100 ng/mLNormalS
2026-03-09Forced vital capacity [Volume] Respiratory system3.3LLower limit of normal about 2.9 L for her age, sex and heightNormalS
2026-03-09Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S

Assessment

Plan of Treatment